The CDC recognizes and approves Ciba Health’s diabetes prevention program to be used in the National Diabetes Prevention Program (DPP)

The CDC recognizes and approves Ciba Health’s diabetes prevention program to be used in the National Diabetes Prevention Program (DPP)

NEW YORK, September 20, 2022 – Ciba Health, best known for its innovative Prediabetes/Diabetes Reversal Programs, has been recognized and approved by the Centers for Disease Control and Prevention (CDC) as part of the National Diabetes Prevention Program (DPP) – the federally backed effort to prevent diabetes in Americans).

According to CDC estimates, 1 in 3 American adults — about 87 million people — has prediabetes. If left untreated, 40% of all American adults will be diagnosed with type 2 diabetes. The cost of care for those with diabetes now accounts for approximately 1 in 4 healthcare dollars spent in the United States.

“Being recognized and approved by the CDC, and included in the National DPP program, means Ciba Health’s novel diabetes programs can reach and help even more Americans suffering from this chronic disease. Chronic illness prevention is one of the biggest challenges of our generation. With this greater reach, more Americans will be able to take advantage of preventive medicine,” said Ciba Health’s Chief Executive Officer, Dr. Innocent Clement. “Ciba Health has demonstrated preventive success in patients exhibiting the precursors to diabetes, plus reversing type 2 diabetes for those who are already diagnosed. CDC approval and support is clearly an important step in our journey.”

Ciba Health uses an individual’s biochemistry to treat their underlying disease, as they understand no two patients are alike. This comprehensive whole-person health approach is designed to get to the root cause of chronic conditions, reduce/eliminate the need for medications, increase energy, improve sleep, and reverse disease.

“We, at SPS Companies, are very excited to offer Ciba’s whole-person, root-cause health solutions to our employees. We started with the Type 2 Diabetes Reversal Program in 2022 and are excited to expand our partnership with Ciba Health by integrating additional precision medicine solutions into our programs. We take the health of our employees very seriously and want to give our employees every tool possible to help them realize and sustain ever-improving health. We truly believe that Ciba Health’s innovative programs can prevent and treat chronic diseases among our employees.” says Corey Kephart, Vice President of Human Resources at SPS Companies.

About DPP

The CDC’s National Diabetes Prevention Program (National DPP) is a partnership of public and private organizations working to prevent or delay type 2 diabetes. Partners make it easier for people at risk for type 2 diabetes to participate in evidence-based lifestyle change programs to reduce their risk of type 2 diabetes.

About Ciba Health

Ciba Heath (cibahealth.com) was established in 2019, with the mission of improving health through precision and personalized medicine. Initially focused on Pre & type 2 diabetes reversal, Ciba has grown its portfolio of products to include Advanced Primary Care, Depression & Anxiety, and Digestive Health. Offering tailored health programs to its patients, Ciba addresses the root cause of a disease with its team of doctors, psychiatrists, health coaches, and nutritionists, leveraging cutting-edge technology for predictive analytics, remote patient monitoring, and digital therapeutic devices for real-time data monitoring.